Terms: = Bone cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
28 results:
1. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract] [Full Text] [Related]
2. Radiation therapy for mucosal melanoma of the head and neck.
Christopherson K; Malyapa RS; Werning JW; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2015 Feb; 38(1):87-9. PubMed ID: 23563215
[TBL] [Abstract] [Full Text] [Related]
3. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
Moroz V; Machin D; Faldum A; Hero B; Iehara T; Mosseri V; Ladenstein R; De Bernardi B; Rubie H; Berthold F; Matthay KK; Monclair T; Ambros PF; Pearson AD; Cohn SL; London WB
Eur J Cancer; 2011 Mar; 47(4):561-71. PubMed ID: 21112770
[TBL] [Abstract] [Full Text] [Related]
4. bone and soft tissue tumours of the foot: review of 83 cases.
Kinoshita G; Matsumoto M; Maruoka T; Shiraki T; Tsunemi K; Futani H; Maruo S
J Orthop Surg (Hong Kong); 2002 Dec; 10(2):173-8. PubMed ID: 12493931
[TBL] [Abstract] [Full Text] [Related]
5. Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience.
Kotz R; Dominkus M; Zettl T; Ritschl P; Windhager R; Gadner H; Zielinski C; Salzer-Kuntschik M
Int Orthop; 2002; 26(4):197-202. PubMed ID: 12185518
[TBL] [Abstract] [Full Text] [Related]
6. Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma.
Yoshida S; Hatori M; Noshiro T; Kimura N; Kokubun S
Arch Orthop Trauma Surg; 2001 Nov; 121(10):598-600. PubMed ID: 11768644
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
[TBL] [Abstract] [Full Text] [Related]
8. Langerhans cell histiocytosis: an uncommon disease commonly manifesting in the craniofacial skeleton.
Martinez-Perez D; Mulliken JB; Arceci RJ
Plast Reconstr Surg; 1996 Aug; 98(2):211-6. PubMed ID: 8764708
[TBL] [Abstract] [Full Text] [Related]
9. [Adamantinoma and osteofibrous dysplasia of the tibia].
Gaubert J; Durroux R
Rev Chir Orthop Reparatrice Appar Mot; 1995; 81(4):333-7. PubMed ID: 8560003
[TBL] [Abstract] [Full Text] [Related]
10. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract] [Full Text] [Related]
11. prognosis of orbital rhabdomyosarcoma in children in Japan.
Takahashi N; Minoda K
Jpn J Ophthalmol; 1991; 35(3):292-9. PubMed ID: 1770669
[TBL] [Abstract] [Full Text] [Related]
12. Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Keating MJ; Kantarjian H; Smith TL; Estey E; Walters R; Andersson B; Beran M; McCredie KB; Freireich EJ
J Clin Oncol; 1989 Aug; 7(8):1071-80. PubMed ID: 2666590
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical and morphologic aspects of benign bone tumors and tumorous bone lesions. Follow-up, therapy and prognosis].
Adler CP; Brendle G
Versicherungsmedizin; 1989 Jul; 41(4):132-8. PubMed ID: 2763407
[TBL] [Abstract] [Full Text] [Related]
14. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic importance of myelosuppression in the response to chemotherapy and survival in advanced ovarian carcinoma.
Sorbe B; Helsing M
Cancer; 1987 Feb; 59(4):690-4. PubMed ID: 3802028
[TBL] [Abstract] [Full Text] [Related]
16. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Danieu L; Wong G; Koziner B; Clarkson B
Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
[TBL] [Abstract] [Full Text] [Related]
17. Management of osteogenic sarcoma patients.
Trapeznikov NN; Yerimina LA; Amiraslanov AT; Sinukov PA
Semin Surg Oncol; 1986; 2(1):1-16. PubMed ID: 3465000
[TBL] [Abstract] [Full Text] [Related]
18. [Prognostic factors in non-Hodgkin's lymphoma in childhood].
Colella R; Loiacono G; Bagnulo S; Demichele N; Diterlizzi M; Amendola F; Ceci A
Pediatr Med Chir; 1985; 7(4):541-4. PubMed ID: 3837217
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical and occult testicular relapses in children with acute lymphoblastic leukemia. Treated with the D.74 and pethema 7/78 protocols].
Ortega JJ; Javier G; Torán N
An Esp Pediatr; 1984 Sep; 21(3):199-214. PubMed ID: 6594962
[TBL] [Abstract] [Full Text] [Related]
20. Osteogenic sarcoma in the American black.
Huvos AG; Butler A; Bretsky SS
Cancer; 1983 Nov; 52(10):1959-65. PubMed ID: 6578868
[TBL] [Abstract] [Full Text] [Related]
[Next]
